Text Size

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams

This study is currently recruiting participants.
Verified March 2013 by University of Michigan
Sponsor:
Collaborators:
General Electric
Philips Medical Systems
Information provided by (Responsible Party):
Hero Hussain, MD, University of Michigan
ClinicalTrials.gov Identifier:
NCT00738712
First received: August 19, 2008
Last updated: March 14, 2013
Last verified: March 2013
History of Changes
  Purpose

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.


Condition Intervention
Healthy
 Procedure: MRI Magnetic Resonance Imaging

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:

MedlinePlus related topics: MRI Scans
U.S. FDA Resources

Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Evaluation of new software in MRI vascular imaging [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    New software technology will be utilized to enhance MRI imaging of the vascular regions of the body.


Estimated Enrollment: 20
Study Start Date: May 2011
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
New hardware or software technologies designed to improve MRI examinations.
 Procedure: MRI Magnetic Resonance Imaging
MRI
Other Name: Magnetic Resonance Imaging

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • male or non-pregnant female patient
  • 18 years or older
  • any ethnic background
  • presenting to MRI for a clinically-ordered chest MRI exam.

Exclusion Criteria:

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • Pregnant patients or patients who are lactating.
  • A patient who is claustrophobic
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00738712

Contacts
Contact: Hero Hussain, MD 734 936-9878 hhussain@umich.edu
Contact: Tamara Harper, LPN CCRC 734 647-9545 tharper@umich.edu

Locations
United States, Michigan
University of Michigan Health Center Recruiting
Ann Arbor, Michigan, United States, 48109
Principal Investigator: Hero Hussain, MD            
Sponsors and Collaborators
University of Michigan
General Electric
Philips Medical Systems
  More Information

No publications provided

Responsible Party: Hero Hussain, MD, Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier: NCT00738712     History of Changes
Other Study ID Numbers: HUM00041815
Study First Received: August 19, 2008
Last Updated: March 14, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
Vascular MRI
Abdominal MRI
Pelvic MRI
Breast MRI
Magnetic Resonance Imaging (MRI)

ClinicalTrials.gov processed this record on May 19, 2013